Precedence Research, Recently Published Report on “N95Medical Protective Masks Market Size, Share, Growth, Trends, Segment Forecasts, Regional Outlook 2020 - 2027”. The report offers an up-to-date analysis regarding the current market scenario, latest trends, key drivers, potential challenges, profitability graph and the overall market environment.
The global N95 Medical Protective Masks Market value is projected to reach US Dollar 1.58 billion by 2027 and is projected to expand at a CAGR of ~XX.X% from 2020 to 2027.
Surgical N95 respirators are frequently employed in healthcare situations and are a subdivision of N95 Filtering Face piece Respirators also known as N95s.An N95 respirator is a respiratory protective device intended to accomplish a very close facemask and offer effectual airborne particles filtration. The edges of the respirator are aimed to form a seal about the mouth and nose. Protective face masks are kind of one time use face cover also comprises air-purifying respirators. Protective face masks have benefits for consumers with respiratory concerns such as lung disease and asthma and consumers with cardiovascular illnesses also select these masks. Protective masks like N95 provide more fortification to health care workers executing medical procedures that may expose them to respiratory secretion of patient.
The N95 graded masks are intended to block more than 95% of test particles those are fewer than or equal to 0.3 microns. The N95 masks cleared by the FDA are named as surgical N95 respirators and are employed in healthcare settings preferably. These respirators obtain a clearance which includes performance testing from testing fluidic resistance and flammability and safety data assessment from biocompatibility testing. There are two kinds of N95 masks available in the market, one having exhalation valve and one deprived of the exhalation valve. The masks having exhalation valve are more favored as it decreases sweat and is stress-free for breathing.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1042
Growth Factors
Emerging and re-emerging communicable sicknesses are appeared to be a communal health threat across the world. Requirement for continuous responsiveness and willingness and attentiveness to deal with communicable disease epidemics has been witnessed, which may lead a hazardous threat to the human kind. The worldwide upsurge in the occurrence of air-borne diseases and contamination levels has been inspiring a substantial number of buyers to opt for disposable face masks.
The N95 grade medical protective masks have been recommended by the healthcare professionals and scientists as preventive equipment from the novel coronavirus infection spreading throughout the world. According to World Health Organization, individuals across 213 nations are suffering from Covid-19 in April, 2020. On account of growing cases of Covid-19 infection, the N95 grade medical protective masks marketplace is projected to observe noteworthy growth prospects during near future.
Report Highlights
- The COVID-19 outbreak has amplified the sale for N95 masks, exclusively for healthcare professionals as this mask is explicitly endorsed for doctors and nurses
- The government organizations across all nations are imposing compulsory act of utilizing the face mask for the fortification from the communicable coronavirus.
- At present, travelers and tourists coming into the metropolises and roaming across the nations are constrained and Covid-19 testing is made mandatory for them.
- In March 2020, Honeywell extended its production competences in Phoenix to manufacture N95 face masks for assistance of U.S. government’s response to COVID19 pandemic.
Buy this Premium Research Report, Click Here@ https://www.precedenceresearch.com/checkout/1042
Regional Snapshots
North America is projected to gather highest chunk of the global N95 mask market revenue throughout the prediction period. Recently, the U.S. FDA has started an emergency usage authorization for the cleansing practice presented by Advanced Sterilization Products that may result in the sterilization of more than 4 million N95 masks on a daily basis. The respirators are cleaned with the help of hydrogen peroxide. More than 9,900 machines are operating currently in the U.S. and every machine is proficient to process more than 480 masks each day. Also shoe companies such as new balance have commenced in producing face masks and they are planning manufacturing more than 100,000 face masks weekly from facility situated in Lawrence and Massachusetts. Such initiatives undertaken by non-healthcare corporations have delivered profitable openings for the N95 grade medical protective masks market growth in this region. Europe is anticipated to emerge as second prevalent market through the prognosis period on account of epidemic of the Covid-19.
Key Players & Strategies
Well-established corporations are expected to goal for geographical expansion, in an attempt to achieve a more substantial brand reputation. Capacity enlargement is estimated to continue as the favored competitive approach for noticeable market contestants to remain competitive. Recently, 3M Company has ramped up its N95 respirators production, doubling its usual output in a response with global shortages of masks caused by Covid-19 outbreak. It is now producing around 100 million N95 respirators per month across the globe, with 35 million of these being manufactured in the U.S. Although 3M endures to govern N95 respirators marketplace, the robust sales growth was also witnessed for smaller companies like Moldex-Metric, Inc. and Alpha ProTech Inc.
Market Segmentation
By Application
- Personal
- Industrial
By Product
- Mask without Exhalation Valve
- Mask with Exhalation Valve
By End-use
- Drug Stores
- Hospitals
- Online Stores
By Regional Outlook
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global N95 Medical Protective Masks Market, By Product
7.1. N95 Medical Protective Masks Market, by Product Type, 2020-2027
7.1.1. Mask without Exhalation Valve
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Mask with Exhalation Valve
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global N95 Medical Protective Masks Market, By Application
8.1. N95 Medical Protective Masks Market, by Application, 2020-2027
8.1.1. Personal
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Industrial
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global N95 Medical Protective Masks Market, By End-use
9.1. N95 Medical Protective Masks Market, by End-use, 2020-2027
9.1.1. Drug Stores
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Online Stores
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global N95 Medical Protective Masks Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End-use (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End-use (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End-use (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End-use (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End-use (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End-use (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End-use (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End-use (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End-use (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End-use (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End-use (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End-use (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End-use (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End-use (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End-use (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End-use (2016-2027)
Chapter 11. Company Profiles
11.1. Honeywell International Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. 3M
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Kowa Company Ltd.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Kimberly-Clark Worldwide, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Prestige Ameritech
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. ANSELL LTD.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Cardinal Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. JIANGSU TEYIN IMP. & EXP. CO., LTD.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. The Gerson Company
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ohlone Press LLC
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Cambridge Mask Co
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1042
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 774 402 6168
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
0 Comments